On the afternoon of March 21, Beijing Mayor Yin Yong met with AstraZeneca's global CEO Soriot. Yin Yong said that with the further comprehensive deepening of reform and expansion of opening up, more pilot and open policies in the pharmaceutical field will be implemented in Beijing faster. We hope that AstraZeneca will make good use of Beijing's advantages, expand its R&D and investment layout in Beijing, promote more R&D pipelines to conduct clinical trials in Beijing, and help Beijing's pharmaceutical and health industry develop with high quality. Soriot said that China is gradually becoming an important source of global scientific and technological innovation. We are willing to further cultivate the Chinese market, take root in Beijing's development, make good use of Beijing's scientific and technological innovation resources, accelerate the implementation of drug R&D and clinical application cooperation in Beijing, achieve better cooperation and win-win results for both sides, and benefit more patients.